| ALS | amyotrophic lateral sclerosis |
| APCs | astrocyte progenitor cells |
| BMSCs | bone marrow-derived mesenchymal stem cells |
| CAR-T | Chimeric Antigen Receptor T-Cell |
| CCL5 | C-C motif chemokine ligand 5 |
| CMC | Chemistry, Manufacturing, and Controls |
| CNS | central nervous system |
| CXCL12 | C-X-C motif chemokine ligand 12 |
| DNPCs | dopaminergic neuron progenitor cells |
| ECG | electrocardiography |
| EGFR | epidermal growth factor receptor |
| ELISA | enzyme-linked immunosorbent assay |
| EMA | European Medicines Agency |
| EOGRTS | Extended One-Generation Reproductive Toxicity Study |
| EpiSCs | human epidermal stem cells |
| ESC | embryonic stem cells |
| EVs | extracellular vesicles |
| FDA | Food and Drug Administration |
| H&E | haematoxylin–eosin |
| hESC-RPE | human embryonic stem cell–derived retinal pigment epithelial cells |
| HLA | human leukocyte antigens |
| HSC | hematopoietic stem cells |
| IAHSCT | immunoablative autologous hematopoietic stem cell transplantation |
| IBD | inflammatory bowel disease |
| ICH | International Conference on Harmonisation |
| IHC | immunohistochemistry |
| iPSCs | induced pluripotent stem cells |
| Ki67 | antigen Kiel 67 |
| KLF4 | Krüppel-like factor 4 |
| MLR | mixed lymphocyte culture reaction |
| MRI | magnetic resonance imaging |
| MSCs | mesenchymal stem/stromal cells |
| NANOG | homeobox protein NANOG |
| NK | natural killer |
| NPCs | neural progenitor cells |
| OCT3/4 | octamer-binding transcription factor 3/4 |
| OPCs | oligodendrocyte progenitor cells |
| PBMCs | peripheral blood mononuclear cells |
| PCOs | primary cholangiocyte organoids |
| PCR | polymerase chain reaction |
| PCNA | proliferating cell nuclear antigen |
| PD | Parkinson disease |
| PET | positron emission tomography |
| PMDA | Pharmaceuticals and Medical Devices Agency |
| SCID | severe combined immunodeficiency |
| SRY | SRY-box transcription factor 2 |
| SPECT | single-photon emission computed tomography |
| SSEA4 | stage-specific embryonic antigen-4 |
| TBI | traumatic brain injury |
| TRA-1-60 | tumor rejection antigen 1-60 |
| TRA-1-81 | tumor rejection antigen 1-81 |
| UC-MSCs | human umbilical cord–derived mesenchymal stem cells |